Jean Jacques Bienaime, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 40,000 shares at $91.26 ($3.6M) on 2024-04-12, disclosed to the SEC on 2024-04-15.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.99 | 20,000 | $1.8M | 49.9% |
| 2 | $91.26 | 20,000 | $1.8M | 50.1% |
| Total | $91.13 avg | 40,000 | $3.6M | 100% |
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |